Refer to Committee
Summary
The Medical Shortage Protection Act prohibits suppliers and health insurers from charging more than 10 % above pre‑shortage prices for prescription drugs, generics, and related devices when a shortage exists. It defines a shortage by federal or state emergency declarations, creates a medical shortage fund, and allows consumers to recover six times their losses plus fees. The bill is currently referred to committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 940 changes status, plus AI-powered summaries and stage predictions.
Sign up free